# Longitudinal Profiling of Plasma N-Glycomic Alterations in an STZ-Induced Mouse Model of Hyperglycemia

**Authors:** Adriána Kutás, Viola Pomozi, Krisztina Fülöp, Béla Viskolcz, Attila Garami, Csaba Váradi

PMC · DOI: 10.3390/ijms27042010 · International Journal of Molecular Sciences · 2026-02-20

## TL;DR

This study tracks changes in blood sugar-related sugar molecule patterns in mice with induced diabetes over time, revealing how these patterns shift with disease progression.

## Contribution

The study provides a detailed longitudinal analysis of plasma N-glycan remodeling in a mouse model of hyperglycemia, linking glycomic changes to metabolic stress.

## Key findings

- Chronic hyperglycemia leads to significant structural remodeling of 20 plasma N-glycan species.
- Bi-antennary glycans decrease while highly sialylated and fucosylated glycans increase with disease progression.
- Glycomic changes closely track metabolic dysregulation and reflect systemic glycosylation responses to glucotoxicity.

## Abstract

The rising global incidence of Type 1 Diabetes Mellitus (T1DM) necessitates a deeper understanding of the molecular shifts underlying its metabolic complications, specifically the role of protein N-glycosylation. This study utilized a streptozotocin-induced C57Bl/6 mouse model to examine temporal changes in plasma N-glycan profiles at 2, 8, and 20 weeks post-induction using HILIC-UPLC-FLR-MS. Following the successful establishment of persistent hyperglycemia and weight loss, glycomic analysis revealed significant structural remodeling of 20 individual glycan species, with complex, multi-sialylated structures proving most sensitive to disease progression. Notably, bi-antennary structures such as A2G1S1, A2G2S1, and A2G2S2(2) exhibited a marked decrease in relative abundance that strongly correlated with elevated blood glucose levels. In contrast, highly sialylated and fucosylated glycans like FA2G2S3 and FA3G3S3 showed a progressive increase over the 20-week period, suggesting an adaptive response to chronic metabolic stress and altered hepatic processing. Our findings demonstrate that chronic hyperglycemia is accompanied by substantial remodeling of the plasma N-glycome, characterized by increased sialylation and fucosylation. These alterations closely track the progression of metabolic dysregulation, suggesting that while they parallel blood glucose trends, they provide a distinct molecular readout of the systemic glycosylation response to glucotoxicity. This study offers a detailed longitudinal characterization of these glycomic changes, highlighting their potential value as descriptive markers of cumulative metabolic stress in rodent models of type 1 diabetes.

## Linked entities

- **Chemicals:** streptozotocin (PubChem CID 29327)
- **Diseases:** Type 1 Diabetes Mellitus (MONDO:0005147), hyperglycemia (MONDO:0002909)

## Full-text entities

- **Genes:** Hp (haptoglobin) [NCBI Gene 15439] {aka HP-1, preHP2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, SLC2A2 (solute carrier family 2 member 2) [NCBI Gene 6514] {aka GLUT2}, St6gal1 (beta galactoside alpha 2,6 sialyltransferase 1) [NCBI Gene 20440] {aka Siat1, St6Gal-I, St6gal, St6galI}
- **Diseases:** weight loss (MESH:D015431), impaired glucose homeostasis (MESH:D044882), insulin deficiency (MESH:D007333), hypoglycemia (MESH:D007003), Diabetes (MESH:D003920), diabetic retinopathy (MESH:D003930), hyperglycemic (MESH:D006944), diabetic complications (MESH:D048909), hyperinsulinemia (MESH:D006946), deficiency (MESH:D007153), injury to (MESH:D014947), chronic inflammation (MESH:D007249), microvascular damage (MESH:D017566), Hyperglycemia (MESH:D006943), neuropathy (MESH:D009422), analgesia (MESH:D000699), metabolic dysregulation (MESH:D021081), metabolic (MESH:D008659), glucose dysregulation (MESH:D018149), hypoinsulinemic (OMIM:240900), necrosis (MESH:D009336), T1DM (MESH:D003922), coronary artery disease (MESH:D003324), diabetic ketoacidosis (MESH:D016883), Type 2 Diabetes (MESH:D003924), autoimmune (MESH:D001327), nephropathy (MESH:D007674)
- **Chemicals:** Sialic acid (MESH:D019158), acetonitrile (MESH:C032159), serine (MESH:D012694), procainamide hydrochloride (MESH:D011342), Glycan (MESH:D011134), Xylazine (MESH:D014991), N (MESH:D009584), ammonium formate (MESH:C030544), tiletamine (MESH:D013992), BioRender (-), ethanolamine (MESH:D019856), Cobalt(II) nitrate hexahydrate (MESH:C025913), saline (MESH:D012965), glucose (MESH:D005947), asparagine (MESH:D001216), DMSO (MESH:D004121), Blood glucose (MESH:D001786), threonine (MESH:D013912), hexosamine (MESH:D006595), sodium acetate (MESH:D019346), acetic acid (MESH:D019342), Heparin (MESH:D006493), Butorphanol (MESH:D002077), Nickel(II) nitrate hexahydrate (MESH:C035197), STZ (MESH:D013311), ammonium hydroxide (MESH:D064753), water (MESH:D014867), Zoletil (MESH:C006131), AGEs (MESH:D017127), zolazepam (MESH:D015041), 2-picoline borane (MESH:C000604853)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940489/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940489/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940489/full.md

---
Source: https://tomesphere.com/paper/PMC12940489